Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Bifidobacterium Longum Subsp. Infantis i18 on Gut Microbiota Development and Health in Early Life
Sponsor: DiproBio (Shanghai) Co., Ltd.
Summary
This study aims to evaluate the effects of Bifidobacterium longum subsp. infantis i18 supplementation on symptoms, gut microbiota development, and overall health outcomes in healthy infants and young children in China.
Official title: Effects of Bifidobacterium Longum Subsp. Infantis i18 Intervention on Early-Life Gut Microbiota Development and Health Outcomes: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Clinical Study
Key Details
Gender
All
Age Range
0 Months - 36 Months
Study Type
INTERVENTIONAL
Enrollment
455
Start Date
2026-11-09
Completion Date
2028-12-31
Last Updated
2026-11-16
Healthy Volunteers
Yes
Interventions
Bifidobacterium longum subsp. infantis i18
Bifidobacterium longum subsp. infantis i18 supplementation.
Placebo
Matching placebo without the probiotic intervention
Locations (1)
First Hospital Hebei North University
Zhangjiakou, Hebei, China